Accessibility Menu
 

Interpharm

(OTC) IPAH

Current Price$0.00
Market Cap$100
Since IPO (1993)-100%
5 Year-100%
1 Year+0%
1 Month+0%

Interpharm Financials at a Glance

Market Cap

$100

Revenue (TTM)

$69.21M

Net Income (TTM)

$29.36M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-581.11 (Low)

Price

$0.00

Volume

15,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

IPAH News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Interpharm

Industry

Pharmaceuticals

Headquarters

Hauppauge, US

IPAH Financials

Key Financial Metrics (TTM)

Gross Margin

29%

Operating Margin

-14%

Net Income Margin

-19%

Return on Equity

0%

Return on Capital

-25%

Return on Assets

-19%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

-0.88%

Stock Overview

Market Cap

$100.00

Shares Outstanding

66.74M

Volume

15.00K

Avg. Volume

724.794

Financials (TTM)

Gross Profit

$21.67M

Operating Income

$10.74M

EBITDA

$8.18M

Operating Cash Flow

$14.11M

Capital Expenditure

$8.00M

Free Cash Flow

$22.11M

Cash & ST Invst.

$72.00K

Total Debt

$26.55M

Interpharm Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q2 2007YOY CHG

Revenue

$16.21M

-7.2%

Gross Profit

$2.27M

-43.8%

Gross Margin

13.99%

N/A

Market Cap

$100.00

N/A

Market Cap/Employee

$0.15

N/A

Employees

670

N/A

Net Income

$10.90M

-164.2%

EBITDA

$2.97M

+18.8%

Quarterly Fundamentals

Name
Q2 2007YOY CHG

Net Cash

$38.43M

-340.4%

Accounts Receivable

$13.72M

+20.9%

Inventory

$12.26M

+25.0%

Long Term Debt

$7.79M

-43.5%

Short Term Debt

$30.68M

+1597.0%

Return on Assets

-18.90%

N/A

Return on Invested Capital

-24.53%

N/A

Free Cash Flow

$6.91M

-53.1%

Operating Cash Flow

$6.35M

-96.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PXYNPraxsyn Corporation
$0.00+0.00%
DNAGDNAPrint Genomics, Inc.
$0.00+0.00%
SPPHSpencer Pharmaceutical Inc.
$0.00+0.00%
MHTXManhattan Scientifics, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
CNSPCns Pharmaceuticals
$7.71+2.34%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.12+0.00%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.74+0.01%
XNDUXanadu Quantum Technologies
$14.68-0.59%

Questions About IPAH

What is the current price of Interpharm?

Interpharm is trading at N/A per share.

What is the 52-week range for Interpharm?

Over the past 52 weeks, Interpharm has traded between N/A and N/A.

How much debt does Interpharm have?

Interpharm total debt is unavailable.

How much cash does Interpharm have on hand?

Interpharm does not have cash on hand data available.

What is Interpharm’s dividend yield?

Interpharm does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.